To further validate the role of the SLC7A11/GPX4 axis in the antidepressant efficacy of nicorandil following TBI, rats were injected with SLC7A11 shRNA to suppress the SLC7A11/GPX4 axis, and subsequent depression‐like behaviors were detected (Figure 4A). Here, GPX4 is linked to depressive symptom measurement.